Showing 1 - 5 of 5
In this article we describe how reimbursement cost-effectiveness thresholds, per unit of health benefit, whether set explicitly or observed implicitly via historical reimbursement decisions, serve as a signal to firms about the commercial viability of their R&D projects (including candidate...
Persistent link: https://www.econbiz.de/10010848921
Persistent link: https://www.econbiz.de/10004015131
Persistent link: https://www.econbiz.de/10007607643
Persistent link: https://www.econbiz.de/10014445526
In this article we describe how reimbursement cost-effectiveness thresholds, per unit of health benefit, whether set explicitly or observed implicitly via historical reimbursement decisions, serve as a signal to firms about the commercial viability of their R&D projects (including candidate...
Persistent link: https://www.econbiz.de/10008459671